Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT00074009 · COMPLETED
Trial details
- NCT number
- NCT00074009
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2005-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.